
About Genome Foundation
Data last updated:
Genome Foundation is a private not for profit company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 09 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73200TG2004NPL043436.
The company has a paid-up capital of ₹81.51 Lakh. It is led by directors including Poorna Chandra Gandhi Kaza (Managing Director) and Kosaraju Rajeswara Rao.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.96 Apoorva Towers Road No.2 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.09 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net loss of ₹4.35 Lakh (net margin -4%) and EBITDA of ₹37,909 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 51% over five years.
The company is associated with 1 brand: Genome Foundation.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomefoundation.in.
Company details
CIN history
Genome Foundation has one previous CIN (Corporate Identification Number): U73200AP2004NPL043436. The current CIN is U73200TG2004NPL043436, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73200TG2004NPL043436 | Current |
| U73200AP2004NPL043436 | Previous |
Contact details
Genome Foundation's registered office is in Hyderabad, Telangana. Its website is genomefoundation.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.96 Apoorva Towers Road No.2 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryLife Sciences, Biotechnology
To see the full contact details of Genome Foundation, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Genome Foundation operates one associated brand: Genome Foundation. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Genetic diagnostics, research, and training services focused on health issues in India. | genomefoundation.in |
Business activity
The main business activity of Genome Foundation is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Genome Foundation, buy the company report.
Financials of Genome Foundation
FY 2025 filings availableGenome Foundation reported revenue of ₹1.09 Cr (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years, including 37% growth in the latest year. EBITDA fell 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37,909 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | -4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genome Foundation, buy the company report.
Board of directors of Genome Foundation
Genome Foundation has 11 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kosaraju Rajeswara Rao Also directs: Woodland Hills Partners LLP | Director | 15 Jul 2020 | 6 Years 4 Months | Current |
| Bhupatiraju Somaraju | Director | 27 Sep 2024 | 2 Years 1 Months | Current |
| Appa Rao Podile | Director | 02 Apr 2022 | 4 Years 7 Months | Current |
| Veerabhadra Rao Arrvapalli | Director | 10 Sep 2019 | 7 Years 2 Months | Current |
| Veera Venkata Satya Gadicharla Kanaka Bhushanam | Director | 27 Sep 2024 | 2 Years 1 Months | Current |
| Veerayya Chowdary Kosaraju Also directs: CCL Products (India) Limited, Reliance Industries Limited, Divi's Laboratories Limited and 5 more | Director | 02 Apr 2022 | 4 Years 7 Months | Current |
Shareholding
The shareholding of Genome Foundation is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions and public shareholders.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public |
To see the full shareholding pattern of Genome Foundation, buy the company report.
Legal cases
No court or tribunal cases involving Genome Foundation are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genome Foundation; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Genome Foundation; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Genome Foundation has 32 board changes on record since 2004: 15 appointments and 17 cessations. The latest: Bhupatiraju Somaraju was appointed as Director on 27 Sep 2024.
23 earlier events are in the company report.
Frequently asked questions
Genome Foundation is an active private not for profit company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 09 June 2004 (22+ years old) and is registered under CIN U73200TG2004NPL043436.
Genome Foundation has 11 current directors:
- Poorna Chandra Gandhi Kaza - Managing Director
- Kosaraju Rajeswara Rao - Director
- Bhupatiraju Somaraju - Director
- Appa Rao Podile - Director
- Veerabhadra Rao Arrvapalli - Director
- Veera Venkata Satya Gadicharla Kanaka Bhushanam - Director
- Veerayya Chowdary Kosaraju - Director
- Pariplavi Mokkapati - Director
- Deep Karan Reddy Adla - Director
- Dasari Prasada Rao - Director
- Reddanna Pallu - Director
The latest financial statements of Genome Foundation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Genome Foundation is U73200TG2004NPL043436. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genome Foundation was incorporated on 09 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bhupatiraju Somaraju was appointed as Director on 27 Sep 2024. Dasari Prasada Rao was appointed as Director on 27 Sep 2024. Deep Karan Reddy Adla was appointed as Director on 27 Sep 2024. Genome Foundation has 32 board changes on record in total.
Genome Foundation can be reached through the website genomefoundation.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Genome Foundation is at Plot No.96 Apoorva Towers Road No.2 Banjara Hills, Hyderabad, Telangana, India – 500034.
Genome Foundation operates in the life sciences industry, in the biotechnology segment.
The compliance status of Genome Foundation is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.

